TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
39.86
-0.34 (-0.85%)
At close: Mar 28, 2025, 4:00 PM
39.78
-0.08 (-0.20%)
After-hours: Mar 28, 2025, 7:56 PM EDT
TG Therapeutics Employees
TG Therapeutics had 338 employees as of December 31, 2024. The number of employees increased by 74 or 28.03% compared to the previous year.
Employees
338
Change (1Y)
74
Growth (1Y)
28.03%
Revenue / Employee
$973,385
Profits / Employee
$69,180
Market Cap
5.79B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
TGTX News
- 8 days ago - Stock Of The Day: TG Therapeutics Breaks Out, May Head Higher - Benzinga
- 14 days ago - Precision & TG Therapeutics: Unlocking Value With ARCUS, BRIUMVI And Azer-Cel - Seeking Alpha
- 15 days ago - TG Therapeutics: Bright Outlook, Bolstered By Briumvi And Upcoming Trials - Seeking Alpha
- 17 days ago - TG Therapeutics: Exciting Briumvi Performance, Looking To Re-Enter - Seeking Alpha
- 22 days ago - TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting - GlobeNewsWire
- 25 days ago - Privia Health, Corcept and three other low-key but high-earnings growth potential stocks to invest in 2025 - Invezz
- 25 days ago - TG Therapeutics: A Wonderful Hold - Seeking Alpha
- 26 days ago - TG Therapeutics, Inc. (TGTX) Q4 2024 Earnings Call Transcript - Seeking Alpha